PIPE-791
PTI-791-101
Phase 1 small_molecule completed
Quick answer
PIPE-791 for Multiple Sclerosis is a Phase 1 program (small_molecule) at Contineum Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Contineum Therapeutics
- Indication
- Multiple Sclerosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed